Atlas Trials

Evaluate Efficacy Levobupivacaine 0.125% Versuss Ropivacaine 0.2% in Hemodynamic Alterations in Labor and Fetal Repercussions

Clinical trial NCT05877131 · UNKNOWN

Trial details

NCT number
NCT05877131
Sponsor
Althaia Xarxa Assistencial Universitària de Manresa
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hemodynamic InstabilityEpiduralPregnancyFetal Cardiac Disorder
Start date
2023-06-01
Primary completion
2023-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.